Toxicity of nitrobenzene compounds towards isolated hepatocytes: dependence on reduction potential

References

• Adams G. E. Hypoxia-mediated drugs for radiation and chemotherapy. Cancer 1981; 48: 696–707
   PubMed Web of Science ®Google Scholar
• Adams G. E., Clarke E. D., Gray P., Jacob R. S., Stratford I. J., Wardman P., Watts M. E., Parrick J., Wallace R. G., Smithen C. E. Structure-activity relationships in the development of hypoxic cell radiosensitizers. International Journal of Radiation Biology 1979; 35: 151–160
   Web of Science ®Google Scholar
• Adams G. E., Clarke E. D., Jacobs R. S., Stratford I. J., Wallace R. G., Wardman P., Watts M. E. Mammalian cell toxicity of nitrocompounds: Dependence upon reduction potential. Biochemical and Biophysical Research Communications 1976; 72: 824–830
   PubMed Web of Science ®Google Scholar
• Adams G. E., Stratford I. J., Wallace R. G., Wardman P., Watts M. E. Toxicity of nitro-compounds towards hypoxic mammalian cells in vitro: Dependence on reduction potential. Journal of the National Cancer Institute 1980; 64: 555–560
   PubMedGoogle Scholar
• Biaglow J. E., Durand R. E. The effects of nitrobenzene derivatives on oxygen utilisation and radiation response of an in vitro tumour model. Radiation Research 1976; 65: 529
   PubMed Web of Science ®Google Scholar
• Biaglow J. E., Jacobson B., Varnes M. The oxidation of ascorbate by electron affinic drugs and carcinogens. Photochemistry and Photobiology 1978; 28: 869–876
   PubMed Web of Science ®Google Scholar
• Chien Y. W., Mizuba S. A. Activity-electroreduction relationship of antimicrobial metronidazole analogues. Journal of Medicinal Chemistry 1978; 21: 374–80
   PubMed Web of Science ®Google Scholar
• Chiu C. W., Lee L. H., Wang C. Y., Bryan G. T. Mutagenicity of some commercially available nitro compounds for Salmonella typhimurium. Mutation Research 1978; 58: 11–22
   PubMed Web of Science ®Google Scholar
• Ehlhardt W. J., Beaulier B. B., Jr., Goldman P. Nitrosoimidazoles: Highly bactericidal analogues of 5-nitroimidazole drugs. Journal of Medicinal Chemistry 1988; 31: 323–329
   PubMed Web of Science ®Google Scholar
• Hansch C., Leo A. Substituent constants for correlation analysis in chemistry and biology. Wiley, New York 1979
   Google Scholar
• Horning D. Distribution of ascorbic acid, metabolites and analogues in man and animals. Annals of the New York Academy of Sciences 1975; 258: 103–118
   PubMed Web of Science ®Google Scholar
• Josephy P. D., Palcic B., Skarsgard L. D. Ascorbate-enhanced cytotoxicity of misonidazole. Nature 1978; 271: 370–372
   PubMed Web of Science ®Google Scholar
• Koch C. J., Howell R. L., Biaglow J. E. Ascorbate anion potentiates cytotoxicity of nitroaromatic compounds under hypoxic and anoxic conditions. British Journal of Cancer 1979; 39: 321–329
   PubMed Web of Science ®Google Scholar
• Kutcher W. W., McCalla D. R. Aerobic reduction of nitrofurazone by rat liver xanthine dehydrogenase. Biochemical Pharmacology 1984; 33: 799–805
   PubMed Web of Science ®Google Scholar
• Modhindra J. K., Rauth A. M. Increased cell killing by metronidazole and nitrofurazone of hypoxic compared to aerobic mammalian cells. Cancer Research 1976; 36: 930–936
   PubMed Web of Science ®Google Scholar
• Moldeus P., Hogberg J., Orrenius S. Isolation of rat hepatocytes. Methods in Enzymology, P. A. Hoffee, M. E. Jones. Academic Press, New York 1978; Vol. 51: 60–71
   Google Scholar
• Moreno S. N. J., Mason R. P., Muniz R. P. A., Cruz F. S., Docampo R. Generation of free radicals from metronidazole and other nitroimidazoles by Tritrichomonas foetus. Journal of Biological Chemistry 1983; 258: 4051–4054
   PubMed Web of Science ®Google Scholar
• Olive P. L. Cytotoxicity and DNA damage to mammalian cells by nitrofurans. Cancer Research 1979 a; 39: 4512–4515
   PubMed Web of Science ®Google Scholar
• Olive P. L. Inhibition of DNA synthesis by nitroheterocycles. British Journal of Cancer 1979 b; 40: 89–93
   PubMed Web of Science ®Google Scholar
• Olive P. L., McCalla D. R. Correlation between metabolic reduction rates and electron affinity of nitroheterocycles. Chemico-Biological Interactions 1977; 16: 223–233
   PubMed Web of Science ®Google Scholar
• Raleigh J. A., Chapman J. D., Borsa J., Kremer W., Rivers A. P. Radiosensitization of mammalian cells by ρ-nitroacetophenone III effectiveness of nitrobenzene analogues. International Journal of Radiation Biology 1973; 23: 377–387
   Web of Science ®Google Scholar
• Rao D. N. R., Jordon S., Mason R. P. Generation of nitro radical anions of some 5-nitrofurans, and 2- and 5-nitroimidazoles by rat hepatocytes. Biochemical Pharmacology 1988; 37: 2907–2913
   PubMed Web of Science ®Google Scholar
• Reynolds A. V. The activity of nitro-compounds against Bacteroides fragilis is related to their electron affinity. Journal of Antimicrobial Chemotherapy 1981; 8: 91–99
   PubMed Web of Science ®Google Scholar
• Rickert D. E. Metabolism of nitroaromatic compounds. Drug Metabolism Reviews 1987; 18: 23–53
   PubMed Web of Science ®Google Scholar
• Silva J. M., Jatoe S. D., O'Brien P. J. GSH may contribute to the cytotoxicity of some nitrosoarenes. Progress in Clinical Pharmacology 1990, (in press)
   Google Scholar
• Tatsumi K., Koga N., Kitamura S., Yoshimura H., Wardman P., Kato Y. Enzymic cistrans isomerization of nitrofuran derivatives. Biochimica et Biophysica Acta 1979; 567: 75–87
   PubMed Web of Science ®Google Scholar
• Verghese A. J., Whitmore G. F. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole. Cancer Research 1980; 40: 2165–2169
   PubMed Web of Science ®Google Scholar
• Wardman P. Reduction potentials of one-electron couples involving free radicals in aqueous solution. Journal of Physical Chemistry Reference Data 1989; 18: 1637–1755
   Web of Science ®Google Scholar
• Wardman P., Clarke E. D. Redox properties and rate constants in free-radical mediated damage. British Journal Cancer 1987; 55: 172–177, Suppl. VIII
   Google Scholar